GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Short Interest

Argos Therapeutics (FRA:77AA) Short Interest


View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Argos Therapeutics's Short Interest

For the Biotechnology subindustry, Argos Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argos Therapeutics's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argos Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Argos Therapeutics's Short Interest falls into.



Argos Therapeutics (FRA:77AA) Business Description

Traded in Other Exchanges
N/A
Address
4233 Technology Drive, Durham, NC, USA, 27704
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines